Protalix Biotherapeutics, Inc. (PLX)
2.78
+0.08
(+2.96%)
USD |
NYAM |
Oct 09, 16:00
2.775
0.00 (0.00%)
After-Hours: 20:00
Protalix Biotherapeutics Price : 2.78 for Oct. 9, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 09, 2026 | 2.70 | 2.785 | 2.69 | 2.78 | 1.199M |
| Oct 08, 2026 | 2.68 | 2.71 | 2.61 | 2.70 | 972851.0 |
| Oct 07, 2026 | 2.70 | 2.765 | 2.68 | 2.71 | 794735.0 |
| Oct 06, 2026 | 2.74 | 2.76 | 2.65 | 2.73 | 934737.0 |
| Oct 05, 2026 | 2.68 | 2.74 | 2.65 | 2.71 | 984061.0 |
| Oct 02, 2026 | 2.70 | 2.72 | 2.64 | 2.71 | 947405.0 |
| Oct 01, 2026 | 2.77 | 2.77 | 2.60 | 2.68 | 1.589M |
| Sep 30, 2026 | 2.69 | 2.815 | 2.68 | 2.76 | 836259.0 |
| Sep 29, 2026 | 2.69 | 2.735 | 2.680 | 2.69 | 898556.0 |
| Sep 28, 2026 | 2.71 | 2.72 | 2.61 | 2.69 | 832815.0 |
| Sep 25, 2026 | 2.76 | 2.775 | 2.70 | 2.72 | 386025.0 |
| Sep 24, 2026 | 2.78 | 2.817 | 2.73 | 2.75 | 302700.0 |
| Sep 23, 2026 | 2.84 | 2.850 | 2.765 | 2.80 | 586410.0 |
| Sep 22, 2026 | 2.75 | 2.84 | 2.75 | 2.84 | 854901.0 |
| Sep 21, 2026 | 2.71 | 2.78 | 2.69 | 2.75 | 471379.0 |
| Sep 18, 2026 | 2.68 | 2.715 | 2.66 | 2.69 | 1.250M |
| Sep 17, 2026 | 2.71 | 2.725 | 2.68 | 2.70 | 321894.0 |
| Sep 16, 2026 | 2.68 | 2.705 | 2.62 | 2.68 | 1.059M |
| Sep 15, 2026 | 2.75 | 2.75 | 2.64 | 2.66 | 812742.0 |
| Sep 14, 2026 | 2.63 | 2.79 | 2.620 | 2.77 | 952160.0 |
| Sep 11, 2026 | 2.74 | 2.75 | 2.615 | 2.64 | 646807.0 |
| Sep 10, 2026 | 2.66 | 2.735 | 2.64 | 2.73 | 782524.0 |
| Sep 09, 2026 | 2.68 | 2.68 | 2.595 | 2.67 | 580004.0 |
| Sep 08, 2026 | 2.66 | 2.67 | 2.60 | 2.65 | 908364.0 |
| Sep 04, 2026 | 2.62 | 2.68 | 2.615 | 2.67 | 863718.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Altimmune, Inc. | 2.61 |
| Taysha Gene Therapies, Inc. | 4.49 |
| Humacyte, Inc. | 0.4053 |
| Agenus, Inc. | 7.67 |
| Amgen, Inc. | 414.87 |
Price Related Metrics
| PE Ratio | 12.24 |
| PS Ratio | 2.818 |
| PEG Ratio | 0.0592 |
| Price to Book Value | 3.137 |
| Price to Free Cash Flow | 29.62 |
| Earnings Yield | 8.17% |
| Market Cap | 223.99M |
| PEGY Ratio | 0.0592 |
| Operating PE Ratio | 9.753 |
| Normalized PE Ratio | 12.25 |